drugset / Trial / NCT01935869

Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100

NCT01935869

Phase 1 Completed 224 enrolled LEO Pharma
RandomizedSingle-groupSingle-blindOther

Summary

The purpose of this study is to determine the skin irritation potential and sensitisation potential of LEO 90100 and the vehicle after repeated applications on the skin of healthy subjects.

Timeline

Start
2013-08
Primary completion
2013-11
Completion
2013-12

Publications

  • Results Queille-Roussel C, Liljedahl M, Clonier F, Lacour JP. Phase I evaluation of the dermal safety of the fixed combination calcipotriene plus betamethasone dipropionate aerosol foam and foam vehicle. J Am Acad Dermatol. 2015:72 Suppl 1;AB211 (P844).

Drugs

EvaluationDrugModalityDoseRoute
Subject LEO 90100 Unknown

Indications